Literature DB >> 26589766

Retuning of Mouse NK Cells after Interference with MHC Class I Sensing Adjusts Self-Tolerance but Preserves Anticancer Response.

Arnika Kathleen Wagner1, Stina Linnea Wickström1, Rossana Tallerico2, Sadia Salam1, Tadepally Lakshmikanth1, Hanna Brauner1, Petter Höglund3, Ennio Carbone2, Maria Helena Johansson1, Klas Kärre4.   

Abstract

Natural killer (NK) cells are most efficient if their targets do not express self MHC class I, because NK cells carry inhibitory receptors that interfere with activating their cytotoxic pathway. Clinicians have taken advantage of this by adoptively transferring haploidentical NK cells into patients to mediate an effective graft-versus-leukemia response. With a similar rationale, antibody blockade of MHC class I-specific inhibitory NK cell receptors is currently being tested in clinical trials. Both approaches are challenged by the emerging concept that NK cells may constantly adapt or "tune" their responsiveness according to the amount of self MHC class I that they sense on surrounding cells. Hence, these therapeutic attempts would initially result in increased killing of tumor cells, but a parallel adaptation process might ultimately lead to impaired antitumor efficacy. We have investigated this question in two mouse models: inhibitory receptor blockade in vivo and adoptive transfer to MHC class I-disparate hosts. We show that changed self-perception via inhibitory receptors in mature NK cells reprograms the reactivity such that tolerance to healthy cells is always preserved. However, reactivity against cancer cells lacking critical MHC class I molecules (missing self-reactivity) still remains or may even be increased. This dissociation between activity against healthy cells and tumor cells may provide an answer as to why NK cells mediate graft-versus-leukemia effects without causing graft-versus-host disease and may also be utilized to improve immunotherapy. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26589766     DOI: 10.1158/2326-6066.CIR-15-0001

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  13 in total

Review 1.  Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.

Authors:  Jeanette E Boudreau; Katharine C Hsu
Journal:  Trends Immunol       Date:  2018-01-31       Impact factor: 16.687

2.  Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.

Authors:  Dhifaf Sarhan; Frank Cichocki; Bin Zhang; Ashley Yingst; Stephen R Spellman; Sarah Cooley; Michael R Verneris; Bruce R Blazar; Jeffrey S Miller
Journal:  Cancer Res       Date:  2016-08-08       Impact factor: 12.701

3.  Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.

Authors:  Lei Shi; Kang Li; Yizhan Guo; Anirban Banerjee; Qing Wang; Ulrike M Lorenz; Mahmut Parlak; Lucy C Sullivan; Oscar Okwudiri Onyema; Saeed Arefanian; Edward B Stelow; David L Brautigan; Timothy N J Bullock; Michael G Brown; Alexander Sasha Krupnick
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-31       Impact factor: 11.205

4.  Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal Cancer.

Authors:  Carino Gurjao; David Liu; Matan Hofree; Saud H AlDubayan; Isaac Wakiro; Mei-Ju Su; Kristen Felt; Evisa Gjini; Lauren K Brais; Asaf Rotem; Michael H Rosenthal; Orit Rozenblatt-Rosen; Scott Rodig; Kimmie Ng; Eliezer M Van Allen; Steven M Corsello; Shuji Ogino; Aviv Regev; Jonathan A Nowak; Marios Giannakis
Journal:  Cancer Immunol Res       Date:  2019-06-19       Impact factor: 11.151

Review 5.  A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells.

Authors:  Rossana Tallerico; Cinzia Garofalo; Ennio Carbone
Journal:  Front Immunol       Date:  2016-05-10       Impact factor: 7.561

6.  IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.

Authors:  Joanna S Kritikou; Carin I M Dahlberg; Marisa A P Baptista; Arnika K Wagner; Pinaki P Banerjee; Lavesh Amar Gwalani; Cecilia Poli; Sudeepta K Panda; Klas Kärre; Susan M Kaech; Fredrik Wermeling; John Andersson; Jordan S Orange; Hanna Brauner; Lisa S Westerberg
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

7.  Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.

Authors:  E Bernson; A Hallner; F E Sander; O Wilsson; O Werlenius; A Rydström; R Kiffin; M Brune; R Foà; J Aurelius; A Martner; K Hellstrand; F B Thorén
Journal:  Leukemia       Date:  2017-05-22       Impact factor: 11.528

8.  Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor Capacity.

Authors:  Arnika K Wagner; Ulf Gehrmann; Stefanie Hiltbrunner; Valentina Carannante; Thuy T Luu; Tanja I Näslund; Hanna Brauner; Nadir Kadri; Klas Kärre; Susanne Gabrielsson
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

9.  Constitutive activation of WASp leads to abnormal cytotoxic cells with increased granzyme B and degranulation response to target cells.

Authors:  Joanna S Kritikou; Mariana Ms Oliveira; Julien Record; Mezida B Saeed; Saket M Nigam; Minghui He; Marton Keszei; Arnika K Wagner; Hanna Brauner; Anton Sendel; Saikiran K Sedimbi; Stamatina Rentouli; David P Lane; Scott B Snapper; Klas Kärre; Peter Vandenberghe; Jordan S Orange; Lisa S Westerberg
Journal:  JCI Insight       Date:  2021-03-22

10.  Expression of CD226 is associated to but not required for NK cell education.

Authors:  Arnika K Wagner; Nadir Kadri; Johanna Snäll; Petter Brodin; Susan Gilfillan; Marco Colonna; Günter Bernhardt; Petter Höglund; Klas Kärre; Benedict J Chambers
Journal:  Nat Commun       Date:  2017-05-31       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.